Clinical Investigator
Similar Posts
Sponsor Responsibilities – Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies
Sponsor Responsibilities – Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence StudiesCDER Guidance Agenda
CDER Guidance AgendaElite Treats LLC Recalls Single Lot of Chicken Chips Due to Salmonella Contamination
February 24, 2026-Elite Treats, LLC. of Boca Raton, FL, is recalling a single lot of “Elite Treats Chicken Chips for Dogs” 6-ounce bags because it may be contaminated with Salmonella. The product is packaged in a 6-ounce black and gold bag marked on the back side with lot number 24045 and an expiratAnesthetic and Analgesic Drug Products Advisory Committee Roster
This page contains the AADPAC roster, which lists the current members and the current number of vacancies for the committee.FDA Approves Labeling Changes to Menopausal Hormone Therapy Products
The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk considerations for these drugs.QuVa Pharma, Inc. Sugar Land, TX. Untitled Letter issued 06/18/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/18/2025
Short Title (70 char) QuVa Pharma, Inc. Sugar Land, TX. Untitled Letter issued 06/18/2025
FEI Number 3012053582
Firm Name QuVa Pharma, Inc
Record Type 483
State TX
Establishment Type Outsourcing Facil